BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pharmacogenetics
,
Doxorubicin
,
rs2476601
,
SLC12A1
,
nitric oxide metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Sema3
Summary
General Info
Curated Studies
Most Correlated Studies
Aortic endothelial cells treated with conditioned media containing PSC1 cleaved or un-cleaved SEMA3E
Retinal endothelial and non-endothelial cell gene expression from Tie2 transgenic mice
Explore Curated Studies Results
Literature
Most Relevant Literature
A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognit…
Semaphorin-3E attenuates intestinal inflammation through the regulation of the communication between…
Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallman…
Semaphorin 3E promote Schwann cell proliferation and migration.
Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node m…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Assessing Sedentary Behaviour in Adults With Type 2 Diabetes - A Randomized Controlled Trial
Vascular Injury in Mechanical Ventilation: a Proof-of-Concept Study
Mobile Health-Health Action Process Approach Based Intervention on Sedentary Behaviour and Stress in…
Hirschsprung Disease Genetic Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ